Literature DB >> 26552985

C5A Protects Macaques from Vaginal Simian-Human Immunodeficiency Virus Challenge.

Ronald S Veazey1, Udayan Chatterji2, Michael Bobardt2, Kasi E Russell-Lodrigue1, Jian Li3, Xiaolei Wang1, Philippe A Gallay4.   

Abstract

A safe and effective vaginal microbicide could decrease human immunodeficiency virus (HIV) transmission in women. Here, we evaluated the safety and microbicidal efficacy of a short amphipathic peptide, C5A, in a rhesus macaque model. We found that a vaginal application of C5A protects 89% of the macaques from a simian-human immunodeficiency virus (SHIV-162P3) challenge. We observed no signs of lesions or inflammation in animals vaginally treated with repeated C5A applications. With its noncellular cytotoxic activity and rare mechanism of action, C5A represents an attractive microbicidal candidate.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26552985      PMCID: PMC4704173          DOI: 10.1128/AAC.01925-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

Review 1.  Considerations and development of topical microbicides to inhibit the sexual transmission of HIV.

Authors:  Jim A Turpin
Journal:  Expert Opin Investig Drugs       Date:  2002-08       Impact factor: 6.206

2.  Pharmacokinetics of a CCR5 inhibitor in rhesus macaques following vaginal, rectal and oral application.

Authors:  R Karl Malcolm; Deborah Lowry; Peter Boyd; Leslie Geer; Ronald S Veazey; Laurie Goldman; P J Klasse; Robin J Shattock; John P Moore
Journal:  J Antimicrob Chemother       Date:  2013-12-30       Impact factor: 5.790

3.  Pharmacokinetics and efficacy of a vaginally administered maraviroc gel in rhesus macaques.

Authors:  R Karl Malcolm; Claire J Forbes; Leslie Geer; Ronald S Veazey; Laurie Goldman; Per Johan Klasse; John P Moore
Journal:  J Antimicrob Chemother       Date:  2012-10-30       Impact factor: 5.790

4.  Sustained local delivery of structurally diverse HIV-1 microbicides released from sublimation enthalpy controlled matrices.

Authors:  Simi Gunaseelan; Philippe A Gallay; Michael D Bobardt; Charlene S Dezzutti; Timothy Esch; Richard Maskiewicz
Journal:  Pharm Res       Date:  2012-06-27       Impact factor: 4.200

5.  Sublimable C5A delivery provides sustained and prolonged anti-HIV microbicidal activities.

Authors:  Richard Maskiewicz; Michael Bobardt; Udayan Chatterji; Simi Gunaseelan; Charlene S Dezzutti; Francois Penin; Philippe A Gallay
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

6.  An intravaginal ring for the sustained delivery of antibodies.

Authors:  Manjula Gunawardana; Marc M Baum; Thomas J Smith; John A Moss
Journal:  J Pharm Sci       Date:  2014-09-17       Impact factor: 3.534

7.  Pharmacokinetics and preliminary safety study of pod-intravaginal rings delivering antiretroviral combinations for HIV prophylaxis in a macaque model.

Authors:  John A Moss; Priya Srinivasan; Thomas J Smith; Irina Butkyavichene; Gilbert Lopez; Amanda A Brooks; Amy Martin; Chuong T Dinh; James M Smith; Marc M Baum
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

8.  Optimization of PCR for quantification of simian immunodeficiency virus genomic RNA in plasma of rhesus macaques (Macaca mulatta) using armored RNA.

Authors:  C J Monjure; C D Tatum; A T Panganiban; M Arainga; V Traina-Dorge; P A Marx; E S Didier
Journal:  J Med Primatol       Date:  2013-11-22       Impact factor: 0.667

9.  An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A.

Authors:  Volker Brass; Elke Bieck; Roland Montserret; Benno Wölk; Jan Albert Hellings; Hubert E Blum; François Penin; Darius Moradpour
Journal:  J Biol Chem       Date:  2001-12-14       Impact factor: 5.157

10.  Structure and function of the membrane anchor domain of hepatitis C virus nonstructural protein 5A.

Authors:  François Penin; Volker Brass; Nicole Appel; Stephanie Ramboarina; Roland Montserret; Damien Ficheux; Hubert E Blum; Ralf Bartenschlager; Darius Moradpour
Journal:  J Biol Chem       Date:  2004-07-07       Impact factor: 5.157

View more
  3 in total

1.  Translational Research in the Nonhuman Primate Model of Tuberculosis.

Authors:  Taylor W Foreman; Smriti Mehra; Andrew A Lackner; Deepak Kaushal
Journal:  ILAR J       Date:  2017-12-01

2.  The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate.

Authors:  Michael Bobardt; Joseph Kuo; Udayan Chatterji; Sumit Chanda; Susan J Little; Norbert Wiedemann; Gregoire Vuagniaux; Philippe A Gallay
Journal:  PLoS One       Date:  2019-02-04       Impact factor: 3.240

3.  Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice.

Authors:  Philippe A Gallay; Udayan Chatterji; Aaron Kirchhoff; Angel Gandarilla; Richard B Pyles; Marc M Baum; John A Moss
Journal:  Open Virol J       Date:  2018-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.